CAS: 186611-11-0

SU5204

SU5204 (3-[(2-Ethoxyphenyl)methylidene]-1H-indol-2-one), an analogue of SU5025, pharmacologically inhibits VEGFR2(IC50s of 4 and 51.5 μM for FLK-1 (VEGFR-2) and

SU5204 is a small molecule drug that has been shown to modulate the activity of tyrosine kinase enzymes, which are involved in regulating cellular growth. SU5204 has been shown to regulate neural plate development and induce apoptosis in cancer cells. This compound also inhibits the proliferation of blood vessels and can be used to prevent or treat cancer. SU5204 inhibits the activity of anilinoquinazolines, which are analogs of hydroxyindole and bind to tyrosine kinases. The inhibition of this enzyme leads to modulation of neural plate development, prevention or treatment of cancer, and regulation of blood vessel growth.